<SEC-DOCUMENT>0001209191-22-005659-index.html : 20220131
<SEC-HEADER>0001209191-22-005659.hdr.sgml : 20220131
<ACCEPTANCE-DATETIME>20220131171632
ACCESSION NUMBER:		0001209191-22-005659
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220127
FILED AS OF DATE:		20220131
DATE AS OF CHANGE:		20220131

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lavelle Erin
		CENTRAL INDEX KEY:			0001737613

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40708
		FILM NUMBER:		22575063

	MAIL ADDRESS:	
		STREET 1:		C/O ALDER BIOPHARMACEUTICALS, INC.
		STREET 2:		11804 NORTH CREEK PARKWAY SOUTH
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eliem Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001768446
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				832273741
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		23515 NE NOVELTY HILL ROAD
		STREET 2:		SUITE B221 #125
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98053
		BUSINESS PHONE:		425-276-2300

	MAIL ADDRESS:	
		STREET 1:		23515 NE NOVELTY HILL ROAD
		STREET 2:		SUITE B221 #125
		CITY:			REDMOND
		STATE:			WA
		ZIP:			98053
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>